F-18 Based PET-CT Tracers Approved in India
I cannot provide a definitive list of F-18 based PET tracers specifically approved for clinical use in India, as the evidence provided does not contain India-specific regulatory approval information.
What the Evidence Shows
The provided guidelines and research discuss various F-18 tracers used internationally, but none of the evidence addresses regulatory approvals specific to India 1. The documents primarily focus on:
Internationally Recognized F-18 Tracers
Based on the 2024 EANM-SNMMI guidelines and research literature, the following F-18 tracers are discussed for clinical use:
Established tracers:
- 2-[18F]FDG (Fluorodeoxyglucose) - Most widely utilized PET agent for oncological imaging 1, 2
- [18F]FES (Fluoroestradiol) - FDA-approved in 2020 for detecting ER-positive lesions in recurrent or metastatic breast cancer 1
- [18F]Sodium fluoride (NaF) - Used for bone imaging with higher sensitivity than conventional bone scans 1, 3
- [18F]Fluciclovine (FACBC) - Amino acid tracer showing promise for certain cancers 1
Emerging tracers mentioned:
- FAPI (Fibroblast activation protein inhibitor) tracers 1
- HER2-targeted radiolabeled antibodies and fragments 1
Critical Gap in Evidence
The evidence provided contains no information about:
- Indian regulatory authority (CDSCO/DCGI) approvals
- India-specific drug labels or guidelines
- Regional availability or approval status in India
Recommendation for Accurate Information
To obtain the definitive list of approved F-18 tracers in India, you must:
- Consult the Central Drugs Standard Control Organisation (CDSCO) database
- Contact the Drug Controller General of India (DCGI)
- Review institutional protocols at major Indian nuclear medicine centers
- Consult the Society of Nuclear Medicine India (SNMI) guidelines
The international guidelines provided are valuable for understanding clinical applications but cannot substitute for India-specific regulatory approval information.